Sudeep Pharma IPO Description – Established in 1989, Sudeep Pharma is a technology-driven manufacturer specializing in excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries. It is among India’s leading producers of mineral-based ingredients, supported by three manufacturing facilities in Vadodara, Gujarat, with a combined annual capacity of 65,579 metric tons (MT) as of 31 December 2024. Its facilities, covering approximately 45,784 square meters, are equipped with advanced automation and hold over 36 global accreditations and 13 product-specific regulatory approvals, including certifications from USFDA, WHO-GMP, ISO, EXCiPACT, FSSC, and BRC.
The company leverages in-house developed technologies such as encapsulation, spray drying, granulation, trituration, liposomal preparations, and blending, enabling it to deliver over 100 products across more than 100 countries. As of 31 December 2024, the company had served over 1,100 customers, including 14 global Fortune 500 companies and marquee names like Pfizer, Merck, Danone, and Intas Pharmaceuticals, with 83.62% of revenue generated from repeat business.
As of 31 December 2024, the company employed a total of 704 permanent employees.
Promoters of Sudeep Pharma – Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani Huf, Riva Resources Private Limited, and Bhayani Family Trust
Sudeep Pharma IPO Details
| Sudeep Pharma IPO Dates | 21 – 25 November 2025 |
| Sudeep Pharma Issue Price | Coming soon |
| Fresh issue | INR 95 crore |
| Offer For Sale | 13,490,726 shares |
| Total IPO size | Coming soon |
| Minimum bid (lot size) | Coming soon |
| Face Value | INR 1 per share |
| Retail Allocation | 35% |
| Listing On | BSE, NSE |
Sudeep Pharma Financial Performance
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | Q1 FY 2026 | |
| Revenue | 344.62 | 428.74 | 459.28 | 502.00 | 124.92 |
| Expenses | 282.46 | 352.28 | 290.56 | 328.48 | 86.00 |
| Net income | 49.80 | 62.32 | 133.15 | 138.69 | 31.27 |
| Margin (%) | 14.45 | 14.54 | 29.00 | 27.63 | 25.03 |
Sudeep Pharma Offer News
Sudeep Pharma Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 (Pre-Issue) | FY 2025 (Post-Issue) | |
| EPS | 5.74 | 12.28 | 12.78 | – |
| PE Ratio | – | – | – |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
| RONW (%) | 30.38 | 27.54 | 37.09 | 27.88 |
| NAV | 15.11 | 20.86 | 33.09 | 45.86 |
| ROCE (%) | 28.45 | 29.40 | 41.17 | 29.82 |
| EBITDA (%) | 21.81 | 23.01 | 40.88 | 39.70 |
| Debt/Equity | 0.38 | 0.32 | 0.17 | 0.20 |
Sudeep Pharma IPO GMP Today (Daily Trend)
Sudeep Pharma Offer Objectives
The company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Capital expenditure towards the procurement of machinery for the production line located at Nandesari Facility I – INR 75.81 crore
- General corporate purposes
Sudeep Pharma IPO Subscription – Live Updates
Coming soon
() Shares allotted to anchor investors are not included in these calculations.
Sudeep Pharma IPO Allotment Status
Sudeep Pharma IPO allotment status will be available on the MUFG Intime India website. Click on this link to get the allotment status.
Sudeep Pharma IPO Dates & Listing Performance
| IPO Opening Date | 21 November 2025 |
| IPO Closing Date | 25 November 2025 |
| Finalization of Basis of Allotment | 26 November 2025 |
| Initiation of refunds | 27 November 2025 |
| Transfer of shares to demat accounts | 27 November 2025 |
| Sudeep Pharma IPO Listing Date | 28 November 2025 |
| Opening Price on NSE | Coming soon |
| Closing Price on NSE | Coming soon |
Sudeep Pharma IPO Reviews – Subscribe or Avoid?
Angel One –
Anand Rathi –
Axis Capital –
Antique Stock Broking –
Arihant Capital –
Ashika Research –
Asit C Mehta –
BP Wealth –
Capital Market –
Canara Bank Securities –
Choice Broking –
Dalal & Broacha –
Elite Wealth –
GCL Broking –
Geojit –
GEPL Capital –
Hem Securities –
ICICIdirect –
Investmentz –
Jainam Broking –
DR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Nirmal Bang –
Reliance Securities –
SBI Securities –
Samco Securities –
SMC Global –
Swastika Investmart –
Ventura Securities –
Sudeep Pharma IPO Lead Manager
ICICI SECURITIES LIMITED
ICICI Venture House, Appasaheb Marathe
Marg Prabhadevi Mumbai 400 025
Phone: +91 22 6807 7100
Email: [email protected]
Website: www.icicisecurities.com
Sudeep Pharma Offer Registrar
MUFG INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West, Mumbai 400 083
Phone: +91 81 0811 4949
Email: [email protected]
Website: www.in.mpms.mufg.com
SUDEEP PHARMA LIMITED
601, 602, 6th floor, Sears Towers-2,
Gotri-Sevasi Road, Sevasi, Vadodara – 391101
Phone: +91 265284 0656/329 1354
Email: [email protected]
Website: www.sudeeppharma.com
Sudeep Pharma IPO FAQs
How many shares in the Sudeep Pharma IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply in the Sudeep Pharma Public Offer?
The best way to apply for Sudeep Pharma’s public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stockbroker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is the Sudeep Pharma IPO GMP today?
Sudeep Pharma IPO GMP today is INR NA per share.
What is the Sudeep Pharma kostak rate today?
Sudeep Pharma kostak rate today is INR NA per application.
What is Sudeep Pharma Subject to Sauda rate today?
Sudeep Pharma Subject to Sauda rate today is INR NA per application.
